PACS developer Intelerad Medical Systems has received 510(k) clearance from the FDA to market and distribute its PET/CT Image Fusion product.
According to the Montreal-based company, its PET/CT Image Fusion functionality can now be sold as a fully integrated module within the firm's IntelePACS product. The company said its PET/CT Image Fusion module is integrated within its InteleViewer viewing software, which allows clinicians to view fused images from IntelePACS workstation.
With fusion and advanced visualization technology, images can be viewed using variable opacity, independent color maps, multiplanar reformatting and maximum intensity projection. Intelerad said that users also have access to specific PET/CT statistics, such as standard uptake values and volume measurements.